{"schema":"hottub-news/story/v1","story":"st_vm462doedwsw5baludka","title":"Candel Therapeutics to Present at the SITC 2026 Annual Meeting","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/candel-therapeutics-to-present-at-the-sitc-2026-annual-meeting-vm462doedw","count":1,"items":[{"id":"n_vm462doedwsw5baludka","seq":1348132,"kind":"press_release","title":"Candel Therapeutics to Present at the SITC 2026 Annual Meeting","url":"https://www.globenewswire.com/news-release/2026/10/02/3373820/0/en/candel-therapeutics-to-present-at-the-sitc-2026-annual-meeting.html","summary":"NEEDHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that the Company will present data from its aglatimagene besadenovec program in non-small cell lung cancer (NSCLC) in patients with progressive NSCLC despite immune checkpoint inhibitor (ICI)…","published":"2026-10-02T13:00:00Z","seen":"2026-10-02T13:07:57Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:cadl","us1374041093"],"entities":[{"id":"Q30283508","name":"Candel Therapeutics","type":"org"},{"id":"Q16900986","name":"Swinomish Indian Tribal Community","type":"event"}],"mentions":2,"story":"st_vm462doedwsw5baludka","category":"economy-business","category_p":0.3100000023841858,"category2":"health","sentiment":"neutral","tone":0.3700000047683716,"political":0.07999999821186066}]}